Quick Answer
BioRestorative Therapies, Inc. reported Total Assets of $4.08 million for fiscal year 2025.
BioRestorative Therapies, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $4.08M | -66.8% |
| 2024 | $12.28M | -2.6% |
| 2023 | $12.61M | -23.3% |
| 2022 | $16.43M | -26.8% |
| 2021 | $22.45M | +416.5% |
| 2020 | $4.35M | +196.5% |
| 2019 | $1.47M | +23.0% |
| 2018 | $1.19M | -32.2% |
| 2017 | $1.76M | +11.3% |
| 2016 | $1.58M | -21.7% |
| 2015 | $2.02M | +19.2% |
| 2014 | $1.69M | +22.3% |
| 2013 | $1.38M | +9.1% |
| 2012 | $1.27M | +473.8% |
| 2011 | $221.0K | -52.8% |
| 2010 | $468.5K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.64M | -61.3% | -33.7% |
| June 30, 2025 | $8.52M | -47.2% | -17.5% |
| March 31, 2025 | $10.33M | -42.5% | -15.9% |
| December 31, 2024 | $12.28M | -2.6% | -15.7% |
| September 30, 2024 | $14.57M | +5.6% | -9.6% |
| June 30, 2024 | $16.12M | +21.2% | -10.2% |
| March 31, 2024 | $17.95M | +27.5% | +42.3% |
| December 31, 2023 | $12.61M | -23.3% | -8.6% |
- BioRestorative Therapies, Inc. showed a decrease of -66.8% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, BioRestorative Therapies, Inc.’s total assets has grown by 770.8% (from $468.5 thousand to $4.08 million).
- The most recent figure is from BioRestorative Therapies, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: